Anna Robeva
Impact in
- Physiology top 0.2%
- Adenosine and Purinergic Signaling
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Adenosine and Purinergic Signaling 9
-
- Lung Cancer Treatments and Mutations 13
- Co-authors
- Joel M Linden (9 shared papers)Diane L. Rosin (2 shared papers)Patrice G. Guyenet (1 shared paper)Heidi E. Taylor (4 shared papers)Amy L. Tucker (4 shared papers)Rüdiger Vallon (3 shared papers)Xiaowei Jin (2 shared papers)Marjo Simonen (1 shared paper)
- Journals
- Annals of Oncology (6 papers)Blood (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Molecular Pharmacology (2 papers)The Journal of Comparative Neurology (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Anna Robeva
38 papers receiving 2.5k citations
Anna Robeva's Hit Papers
Peers
Comparison fields: 5 of 95
- Physiology 699
- Pulmonary and Respiratory Medicine 684
- Cellular and Molecular Neuroscience 314
- Pathology and Forensic Medicine 163
- Developmental Neuroscience 28
Countries citing papers authored by Anna Robeva
This map shows the geographic impact of Anna Robeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Robeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Robeva more than expected).
Fields of papers citing papers by Anna Robeva
This network shows the impact of papers produced by Anna Robeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Robeva. The network helps show where Anna Robeva may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Robeva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer Hit paper breakdown → | 2020 | 743 |
| 2 | 1998 | 355 | |
| 3 | 2003 | 351 | |
| 4 | 1993 | 186 | |
| 5 | 2001 | 146 | |
| 6 | 1999 | 113 | |
| 7 | 2007 | 105 | |
| 8 | 1994 | 81 | |
| 9 | 1996 | 76 | |
| 10 | 1996 | 67 | |
| 11 | 2002 | 51 | |
| 12 | 1992 | 49 | |
| 13 | 2024 | 42 | |
| 14 | 1999 | 33 | |
| 15 | 2014 | 33 | |
| 16 | 2018 | 30 | |
| 17 | Synthetic and endogenous inhibitors of snake venom metalloproteinases. | 1991 | 27 |
| 18 | 2008 | 26 | |
| 19 | 1993 | 18 | |
| 20 | 2001 | 15 |
About Anna Robeva
Anna Robeva is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Pharmacology and Molecular Biology, having authored 38 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Adenosine and Purinergic Signaling (9 papers), Receptor Mechanisms and Signaling (7 papers), Lymphoma Diagnosis and Treatment (3 papers), Iron Metabolism and Disorders (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Venomous Animal Envenomation and Studies (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Physiology (699 citations), Pulmonary and Respiratory Medicine (684 citations), Cellular and Molecular Neuroscience (314 citations), Pathology and Forensic Medicine (163 citations) and Developmental Neuroscience (28 citations). Anna Robeva has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Joel M Linden, Diane L. Rosin, Patrice G. Guyenet, Heidi E. Taylor, Amy L. Tucker, Rüdiger Vallon, Xiaowei Jin, Marjo Simonen, Andrea B. Huber and Christine E. Bandtlow. Their work appears in journals such as Annals of Oncology, Blood, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology and The Journal of Comparative Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.